Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days
Authors:
- T.J. O'ROurkeTOT.J. O'ROurke
- T.D. BrownTBT.D. Brown
- K. HavlinKHK. Havlin
- J.G. KuhnJKJ.G. Kuhn
- J.B. CraigJCJ.B. Craig
- H.A. BurrisHBH.A. Burris
- W.G. SatterleeWSW.G. Satterlee
- P.G. TarassoffPTP.G. Tarassoff
- D.D. Von HoffDHD.D. Von Hoff
- 1 January 1994
- journal article
- other
- Published by Elsevier in European Journal of Cancer
- Vol. 30 (3) , 417-418
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.Journal of Clinical Oncology, 1991
- Side effects of 6‐azauridine triacetate in rheumatoid arthritisClinical Pharmacology & Therapeutics, 1970